Lisdexamfetamine dimesylate in ADHD phase 3 data presented
...d today that their investigational ADHD treatment, lisdexamfetamine dimesylate (also known as NRP104 or LDX), yielded ...ed that at 6 months, 95 percent of children taking lisdexamfetamine dimesylate (NRP104/LDX) produced a "much improved" or "very much improved" rating on the Clinical Gl...Abuse liability study results of lisdexamfetamine dimesylate (NRP104) presented at CPDD
...that results of three abuse liability studies with lisdexamfetamine dimesylate (NRP104), an investigational drug for t...River Pharmaceuticals Inc. (NASDAQ: NRPH) designed lisdexamfetamine dimesylate as an inactive prodrug in which d-amphetamine is bonded to l-lysine, a naturally occurrin...NRP104 significantly reduced symptoms of attention deficit hyperactivity disorder in children
...oday that treatment with the investigational drug, lisdexamfetamine dimesylate (NRP104), demonstrated statistically si...ociation (APA) annual meeting. A phase II trial of lisdexamfetamine dimesylate (NRP104), also presented at APA today, demonstrated a statistically significant reduction...